Imagin Medical Inc. (IMEXF)
| Market Cap | 11.00 |
| Revenue (ttm) | n/a |
| Net Income | -2.51M |
| EPS | -0.23 |
| Shares Out | 10.83M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 355 |
| Open | 0.000001 |
| Previous Close | 0.000001 |
| Day's Range | 0.000001 - 0.000001 |
| 52-Week Range | 0.000001 - 0.0001 |
| Beta | 1.77 |
| Analysts | n/a |
| Price Target | n/a |
| Est. Earnings | Dec 22, 2026 |
About Imagin Medical
Imagin Medical Inc., a urologic oncology company, focuses on the research, development, and commercialization of medical devices in the bio-chemistry industry. It has a license agreement with Lawrence Livermore National Security, LLC to develop, manufacture, and sell a medical imaging device. The company is headquartered in Vancouver, Canada. [Read more]
News
Ponce Therapeutics Executes Worldwide Exclusive License to Speratum Biopharma's Nano-in™ and No-Pass Mimic™ Nanoparticle Technologies in Anti-Aging and Other Products Initially for Skin
Ponce Therapeutic's ("Ponce") lead product, ReBeaut™, is a microneedle patch containing nanoparticles carrying its proprietary ApoptiCIDe™ cell elimination gene therapy technology targeting senescent...
Imagin Medical Announces Stock Option Grants
VANCOUVER, BC and BOSTON , April 22, 2022 /PRNewswire/ -- Imagin Medical (CSE: IME) (OTCQB: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) ("Imagin" or the "Company") today announced today that, pursuant...
Imagin Medical Announces Appointment of Kayvon Namvar to Board of Directors and Kevin Slawin, M.D. as Board Chairman
VANCOUVER, BC and BOSTON, Nov. 8, 2021 /PRNewswire/ -- Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) ("Imagin" or the "Company"), a surgical imaging company visualizing cancer in vital new ways starti...
Rapha Capital Leads New $3 Million Convertible Note Financing in Imagin Medical, Inc.
MIAMI and VANCOUVER, BC and BOSTON, Aug. 30, 2021 /PRNewswire/ -- Rapha Capital Management, LLC ("Rapha Capital") today announces it has closed a new convertible note offering totaling US $3 million i...
Imagin Medical Secures New $3 Million Convertible Note Financing
VANCOUVER, British Columbia, BOSTON and MIAMI, Aug. 26, 2021 (GLOBE NEWSWIRE) -- via InvestorWire -- Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (“Imagin” or the...
Imagin Medical on Schedule for American Urology Association Demonstration
VANCOUVER, British Columbia, and BOSTON, Aug. 17, 2021 (GLOBE NEWSWIRE) -- via InvestorWire -- Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (“Imagin” or the “Comp...
IMAGIN MEDICAL REPORTS COMPANY ON SCHEDULE FOR PRODUCT DEMONSTRATION
Vancouver, B.C. and Boston, MA, May 19, 2021 (GLOBE NEWSWIRE) -- via InvestorWire -- Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (“Imagin” or the “Company”) toda...
IMAGIN MEDICAL REPORTS MANUFACTURING PROGESS
VANCOUVER, B.C. / BOSTON, March 16, 2021 (GLOBE NEWSWIRE) -- via InvestorWire – Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (“Imagin” or the “Company”) today rep...
IMAGIN MEDICAL CLOSES SECOND TRANCHE OF CONVERTIBLE NOTE OFFERING
Vancouver, B.C. and Boston, MA, Feb. 18, 2021 (GLOBE NEWSWIRE) -- via InvestorWire -- Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) (Frankfurt & Stuttgart Symbol: DPD3) (“Imagin” or the “Company”) to...
Imagin Medical Engages Torrey Hills Capital
VANCOUVER, British Columbia, and BOSTON, Jan. 20, 2021 (GLOBE NEWSWIRE) -- via InvestorWire – Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) (FSE: DPD2) ("Imagin" or the "Company") is pleased to announ...
Imagin Medical Builds Momentum for 2021
VANCOUVER, British Columbia, and BOSTON, Jan. 13, 2021 (GLOBE NEWSWIRE) -- via InvestorWire – Imagin Medical (CSE: IME) (OTC: IMEXF) (FRA: DPD2) (the “Company”) announces that critical milestones met ...